市場調査レポート
商品コード
1429017
関節鏡検査機器の世界市場の評価:用途別、タイプ別、最終用途別、地域別、機会、予測(2017年~2031年)Arthroscopy Devices Market Assessment, By Use, By Type, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
関節鏡検査機器の世界市場の評価:用途別、タイプ別、最終用途別、地域別、機会、予測(2017年~2031年) |
出版日: 2024年02月20日
発行: Market Xcel - Markets and Data
ページ情報: 英文 223 Pages
納期: 3~5営業日
|
世界の関節鏡検査機器の市場規模は、2023年の50億4,000万米ドルから2031年に78億2,000万米ドルに達し、予測期間の2024年~2031年にCAGRで5.65%の成長が見込まれています。市場は、技術の進歩、老年人口の増加、スポーツ関連傷害の増加、侵襲性の低い手術オプションへの関心の高まりなどの主な要因によって形成されています。優れた高精細画像や改良された手術器具などの関節鏡技術の進歩は、関節鏡手術の有効性と成功率を大幅に向上させ、世界の関節鏡検査機器市場の成長を促進しています。これらの発展により、より正確で侵襲の少ない手術が可能になり、その結果、患者の回復期間が短縮され、治療成績が向上しています。
変形性関節症のような関節疾患に罹患しやすい高齢者の増加は、世界の関節鏡検査機器市場の拡大に不可欠です。このような人口動態の変化は、関節を温存および修復する手術に対する需要の高まりに拍車をかけ、多くの場合、関節鏡下で行われます。市場は、特に若いアスリートや活動的な人々の間での、スポーツ関連傷害の増加によってさらに牽引されています。世界中でスポーツに参加する人が増えるにつれ、関節の損傷はより一般的になり、関節鏡手術が必要とされています。
さらに、世界の関節鏡検査機器市場では、低侵襲手術への志向が高まっています。従来の観血的手術に比べて、切開創が小さい、不快感や傷跡が少ない、感染可能性が低い、回復が早いなどの多くの利点があるため、関節鏡手術は世界中の医療産業でますます普及しています。関節鏡手術は、スポーツに関連した障害の治療に向け、世界中のさまざまな病院で広く受け入れられています。
例えば、2023年11月、インドのKalinga Institute of Medical Sciences(KIMS)は、スポーツ関連傷害の治療を受けるアスリートが効果的かつ迅速に回復できるよう、大きな措置を講じました。これは、オディシャ州がインドにおけるスポーツの中心地として急速に脚光を浴びるようになったことに対応したものです。このワークショップでは、関節の治療を大きく変えつつあり、アスリートも頻繁に利用する関節鏡手術について、解剖用の死体を使ったワークショップを開催しました。
スポーツ関連傷害の増加
スポーツ関連傷害の増加が、世界の関節鏡検査機器市場の伸びに大きく寄与しています。関節鏡検査は、膝、肩、肘、手首、足首、股関節などの関節の問題を診断および治療するために使用される低侵襲手術法です。多くのスポーツに参加するアスリートは、軟骨や靭帯の損傷など、関節の疾患にかかるリスクが高まっています。効果的な診断/治療ツールへのニーズの高まりは、スポーツ関連傷害の増加によってもたらされ、それが関節鏡検査機器市場を牽引しています。スポーツ医療では、低侵襲手術、痛みや感染の懸念の軽減、回復期間の短縮といった利点から、これらの機器が好まれています。
2023年にAmerican Academy of Orthopaedic Surgeons(AAOS)Annual Meetingで発表された研究によると、スポーツ関連傷害の重症度は一般的に低下していますが、頭頸部傷害の発生率は増加しています。「Epidemiology of Sports Injuries Among High School Athletes in the U.S.」という研究によると、全国で報告されたスポーツ傷害は522万8,791件でした。
市場を後押しする技術の進歩
技術開発は世界の関節鏡検査機器市場に大きな影響を与えています。改良された手術器具や高精細画像を含む重要な進歩は、関節鏡手術の精度と有効性を大幅に向上させました。これらの開発により、外科医はより正確で侵襲の少ない手術を行うことができるようになり、患者の転帰を改善し、回復時間を短縮することができるようになりました。その結果、こうした先進の医療機器に対するニーズが高まっています。低侵襲整形外科手術の範囲を拡大することで、3Dイメージングや手術中のロボット支援など、この産業における継続的な技術の進歩が、世界の関節鏡検査機器市場の成長を支え続けています。
当レポートでは、世界の関節鏡検査機器市場について調査分析し、市場規模と予測、市場力学、主要企業情勢と見通しなどを提供しています。
Global arthroscopy devices market is projected to witness a CAGR of 5.65% during the forecast period 2024-2031, growing from USD 5.04 billion in 2023 to USD 7.82 billion in 2031. The global arthroscopy devices market is shaped by key factors, including technological advancements, an increasing elderly population, a rise in sports-related injuries, and a heightened interest in less invasive surgical options. Advances in arthroscopic technology, such as superior high-definition imaging and improved surgical tools, have significantly enhanced the effectiveness and success rates of arthroscopic procedures, thereby propelling the growth of global arthroscopy devices market. These developments lead to more accurate and less intrusive surgeries, resulting in shorter recovery periods and better outcomes for patients.
The growing number of older adults, more susceptible to joint conditions like osteoarthritis, is critical in expanding the global arthroscopy devices market. This demographic shift spurs a higher demand for surgeries that preserve and repair joints, often performed arthroscopically. The market is further driven by the rise of sports-related injuries, especially among younger athletes and active individuals. As more people participate in sports globally, joint injuries are becoming more common and necessitating arthroscopic procedures.
Furthermore, the global arthroscopy devices market has a growing tendency towards less invasive surgeries. With its many advantages over traditional open operations, such as smaller incisions, less discomfort and scars, a decreased chance of infection, and a quicker recovery, arthroscopy is becoming increasingly popular in the healthcare industry worldwide. Arthroscopy is widely accepted in various hospitals across the world for the treatment of sports-related injuries.
For example, in November 2023, the Kalinga Institute of Medical Sciences (KIMS) in India took major steps to ensure athletes receiving treatment for sports-related injuries recover effectively and quickly. This was in response to Odisha's rapid rise to prominence as a sports hub in India. It arranged a workshop using cadavers on Arthroscopic Surgery, which is transforming joint treatments and is frequently used by athletes.
Rise in Sports-Related Injuries
An increasing number of sports-related injuries is largely responsible for the rise of the global arthroscopy devices market. Arthroscopy is a minimally invasive surgical method used to diagnose and treat problems in joints, such as the knee, shoulder, elbow, wrist, ankle, and hip. Athletes who participate in more sports are at an increased risk of suffering from joint ailments, including cartilage and ligament damage. Increased need for effective diagnostic and therapeutic tools is brought about by the rise in sports-related injuries, which, in turn, drives the market for arthroscopy equipment. Sports medicine favors these devices because of their advantages, which include less invasive surgery, reduced pain and infection concerns, and quicker recovery periods.
According to a study presented at the 2023 American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting, the incidence of head and neck injuries is increasing while the severity of sports-related injuries is decreasing generally. According to the study "Epidemiology of Sports Injuries Among High School Athletes in the U.S.," there were 5,228,791 sports injuries reported nationwide.
Technological Advancements Fueling the Market
Technological developments have a major impact on the global arthroscopy devices market. Important advancements including improved surgical instruments and high-definition imaging have significantly raised the calibre and effectiveness of arthroscopic procedures. These developments enable surgeons to do operations with increased accuracy and less invasiveness, improving patient outcomes and reducing recovery times. As a result, there is an increased need for these advanced medical gadgets. By expanding the range of minimally invasive orthopaedic procedures, ongoing technical advancements in this industry, such as 3D imaging and robotic assistance during surgeries, continue to support the growth of global arthroscopy devices market.
For example, in January 2024, TheNanoExperience.com, which is a new patient-focused resource from Arthrex, a leader in minimally invasive surgical technology and surgical skills education, was launched. It highlights the science and advantages of Nano arthroscopy, a cutting-edge, minimally invasive orthopaedic procedure that may enable a speedy return to activity and less pain.
Growing Demand of Arthroscopy Devices for Surgical Procedures
The growing use of arthroscopy devices in surgical operations is driving a significant expansion in the global market. As a less invasive surgical technique, arthroscopy has gained popularity in diagnosing and treating joint issues, particularly those affecting the knees, shoulders, and hips. This preference is explained by the many benefits of arthroscopy over open operations, including fewer surgical incisions, less pain, a lower risk of complications, and a quicker recovery. The need for arthroscopic procedures has increased due to an increase in age-related joint disorders, sports-related injuries, and an ageing population. The global arthroscopy devices market is expanding due to the increasing use of arthroscopy devices in medical operations, fueled by the growing demand.
The launch of Integrated Endoscopy's second generation NUVIS Single-Use Arthroscope, a first-of-its-kind 4K endoscope intended for use in arthroscopic surgical procedures, was announced in December 2022. Integrated Endoscopy is a medical device company leading the development of 4K, low-cost, single-use endoscopes for the arthroscopic surgery market.
Growing popularity of Radio-Frequency Ablation Systems
The growing need for radio-frequency ablation (RFA) systems is propelling the growth of the global arthroscopy devices market. RFA systems are increasingly used in arthroscopic procedures, particularly for treating chronic joint pain. RFA systems use thermal energy to target and impair nerve activity, lowering pain. The necessity for effective pain treatment approaches has increased due to the rising prevalence of joint problems, sports-related injuries, and an aging population. One important answer to this problem is the use of RFA systems. RFA treatments are becoming increasingly common because of their efficiency, safety record, and ability to hasten recovery. This, in turn, is driving the demand for arthroscopy equipment.
For example, NeuroOne's radiofrequency ablation system was approved by the US Food and Drug Administration (FDA) in December 2023. The firm plans to launch the device in the first half of 2024. With the 510(k) clearance, neurosurgeons can now utilize the OneRF device on patients who require nerve tissue lesions for functional neurosurgery procedures.
North America Dominates the Market
Due to several important considerations, North America holds a dominant position in the global arthroscopy devices market. The area has a large senior population that is susceptible to joint illnesses like arthritis and has a high rate of sports-related injuries, which raises the need for arthroscopic procedures. Furthermore, many well-known medical device manufacturers who create and produce state-of-the-art arthroscopy equipment are based in North America, particularly in the United States. The region's sophisticated medical technology is easier to adopt due to its well-developed healthcare infrastructure, high healthcare spending, and accommodating reimbursement rules. The need for arthroscopy equipment is further increased by focusing on minimally invasive surgical methods in North American medical practice.
For example, following this year's first-in-human surgery, Pristine Surgical, a New Hampshire-based medical device company, introduced Summit 4K, a single-use surgical arthroscope, in US facilities in November 2023. After the FDA 510(K) authorized device was deployed for the first time at the Southern California Orthopaedic Institute in April, it was fully released onto the US market.
Future Market Scenario (2024 - 2031F)
Ongoing advancements in arthroscopic equipment technology are improving the accuracy and efficacy of arthroscopic procedures. This includes enhanced imaging systems, more compact and pliable devices, and cutting-edge materials.
The global arthroscopy devices market is being further driven by the growing popularity of arthroscopy, a less invasive surgery, for diagnosing and treating joint problems.
Changes in health insurance payment rules and government laws may have a major impact on the market, affecting the accessibility and use of arthroscopy-based treatments.
The global arthroscopy devices market may also encounter obstacles, including the high cost of implants and arthroscopic procedures, which put patients at a financial disadvantage, particularly in areas with low healthcare resources.
Key Players Landscape and Outlook
Mergers and acquisitions (M&A) significantly affect the global arthroscopy devices market since they lead to market consolidation and improve business capabilities. Companies merge their resources, knowledge, and technology through M&A, which promotes improved R&D. The creation of increasingly complex and efficient arthroscopy instruments is frequently the result of this integration. Additionally, through mergers and acquisitions, businesses can increase their market reach and geographic reach, which makes it easier for them to reach new clientele and distribute their goods more widely. The global arthroscopy devices market is growing because of this consolidation, which usually leads to a more dominant market position and a stronger competitive edge.
For example, in January 2023, the publicly traded medical device business Zimmer Biomet inked a definitive deal to pay USD 155 million to buy Embody, a medical device company based in the United States. Zimmer will purchase Embody's whole line of collagen-based biointegrative products as part of the deal. The TAPESTRY biointegrative implant for tendon healing and the TAPESTRYRC arthroscopic implant system for rotator cuff repair are two of these treatments for orthopaedic soft tissue injuries.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.